Latest in Finance

Icosagen completes €45m expansion to bring discovery, development and GMP manufacturing under one roof

The expansion enables Icosagen to support biotechnology and biopharmaceutical companies globally across discovery, developability assessment, CMC development and Phase I/II GMP manufacturing within one integrated organisation at a single site

Find out more
Icosagen completes €45m expansion to bring discovery, development and GMP manufacturing under one roof

Siemens and IFS partner to close the loop across the product lifecycle with industrial AI

Siemens and IFS partner to close the loop across the product lifecycle with industrial AI

Siemens and IFS have partnered to help manufacturers connect engineering intelligence with operational reality — increasing the value of their products and optimising their...
See more
Adragos signs agreement with Towa Pharmaceutical to supply off-patent medicines

Adragos signs agreement with Towa Pharmaceutical to supply off-patent medicines

Adragos Pharma Kawagoe KK has announced the signing of an agreement with Towa Pharmaceutical Co., Ltd, to establish a strategic collaboration aimed at ensuring the stable supply of off-patent pharmaceuticals
Lonza expands HPAPI capacity in Visp to boost its position in payload-linker manufacturing

Lonza expands HPAPI capacity in Visp to boost its position in payload-linker manufacturing

Investment supports Lonza’s position in the ADC space by further developing its integrated ADC offering and expanding commercial-scale supply of highly potent payload-linker molecules
SCHOTT Pharma invests in sterile cartridge production in Hungary

SCHOTT Pharma invests in sterile cartridge production in Hungary

SCHOTT Pharma breaks ground for a new production facility for ready-to-use cartridges in Hungary
Merck to acquire Bio-Techne for $11.3bn, expanding bioprocessing and cell therapy capabilities

Merck to acquire Bio-Techne for $11.3bn, expanding bioprocessing and cell therapy capabilities

The deal will add proteomics, spatial biology and cell therapy manufacturing technologies to Merck's Process Solutions business, with $140m in annual synergies targeted by year three
Celerion expands Zurich bioanalytical laboratory to meet growing market demand

Celerion expands Zurich bioanalytical laboratory to meet growing market demand

Located in one of Europe’s leading life sciences hubs, the Zurich facility serves as a key component of the company’s global bioanalytical network.
Clean Cells acquires Stem Genomics to expand cell therapy QC

Clean Cells acquires Stem Genomics to expand cell therapy QC

French biopharma QC specialist Clean Cells has bought Stem Genomics, adding genomic stability testing for stem cell therapies and strengthening its US footprint in Durham, North Carolina
Aplagon closes €4.8m round to advance first-in-class antithrombotic APAC into Phase II AVF trial

Aplagon closes €4.8m round to advance first-in-class antithrombotic APAC into Phase II AVF trial

The financing supports a European CTA filing with the EMA for arteriovenous fistula maturation failure in end-stage kidney disease, expanding APAC's clinical programme across thrombo-inflammatory indications
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence

Latest posts in Finance

ARK Invest backs Cellares to mass manufacture cell therapies with $20m investment

ARK Invest backs Cellares to mass manufacture cell therapies with $20m investment

The ARK Venture Fund has previously invested in tech platforms such as OpenAI and Anthropic and is now backing the life sciences company to solve cell therapy's scaling problem
AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn

AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn

AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
GSK acquires Nuvalent for $10.6bn to accelerate NSCLC pipeline with FDA-reviewed ROS1 and ALK inhibitors

GSK acquires Nuvalent for $10.6bn to accelerate NSCLC pipeline with FDA-reviewed ROS1 and ALK inhibitors

GSK has agreed to acquire clinical-stage oncology company Nuvalent for $10.6bn, securing two late-stage next-generation kinase inhibitors — zidesamtinib and neladalkib — currently under FDA review for potential 2026 approval in non-small cell lung cancer
UK healthcare M&A drops 26% in Q1 2026 amid geopolitical tension and financing pressures

UK healthcare M&A drops 26% in Q1 2026 amid geopolitical tension and financing pressures

Heligan Group's latest report records just 53 deals, down from 72 in Q1 2025, with pharma and life sciences remaining most active despite tighter financing conditions and prolonged deal timelines
You need to be a subscriber to read this article.
Click here to find out more.
ADC funding, spatial biology investment and haematology M&A signal biopharma pipeline momentum

ADC funding, spatial biology investment and haematology M&A signal biopharma pipeline momentum

From a $86.6m Series B for first-in-class ADCs to a $1.25bn haematology acquisition, this week's deals reflect sustained biopharma investment in next-generation therapeutic platforms
Strengthening US pharmaceutical supply: SCHOTT Pharma inaugurates expanded vial production in Lebanon, PA

Strengthening US pharmaceutical supply: SCHOTT Pharma inaugurates expanded vial production in Lebanon, PA

SCHOTT Pharma has inaugurated new production lines for both standard and sterile ready-to-use (RTU) glass vials designed to store a wide range of drugs — from biologics and other complex injectable therapies to vaccines and emergency room medications
T-CURX acquires Pantherna Therapeutics to fast-track non-viral in vivo CAR-T pipeline

T-CURX acquires Pantherna Therapeutics to fast-track non-viral in vivo CAR-T pipeline

Combining transposon-based CAR-T with Pantherna's LNP and mRNA platforms, T-CURX aims to accelerate clinical trials by a year and become Europe's first biotech with both technologies in-house
CordenPharma acquires AmbioPharm to build three-continent peptide API network

CordenPharma acquires AmbioPharm to build three-continent peptide API network

The deal adds US and Shanghai manufacturing sites to CordenPharma's existing platform, giving pharma customers greater flexibility across SPPS, LPPS and hybrid peptide synthesis at commercial scale
Eli Lilly to expand into infectious disease with $4bn triple vaccine acquisition

Eli Lilly to expand into infectious disease with $4bn triple vaccine acquisition

The pharma giant has reportedly agreed to acquire Curevo, LimmaTech Biologics and Vaccine Co in a strategic push beyond its blockbuster obesity franchise
Bora Group to acquire MacroGenics’ manufacturing operations and CDMO business

Bora Group to acquire MacroGenics’ manufacturing operations and CDMO business

The purchase will hand the Group a biologics drug substance manufacturing facility and a warehousing centre in Maryland, which Bora plans to use in cooperation with Tanvex Biopharma to scale its end-to-end biologics platform
Cambridge biotech Verinnogen secures £500k CPI investment to advance cancer drug development

Cambridge biotech Verinnogen secures £500k CPI investment to advance cancer drug development

The investment will advance a handheld device delivering more precise and reproducible tumour size measurements in preclinical oncology research, addressing variability in existing techniques that can slow drug development and necessitate costly repeat studies

Sponsor content

Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe

Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe

After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity...
Almac group delivers record year of growth

Almac group delivers record year of growth

Revenue rises to £1.1 billion as profit increases 16% and workforce expands to more than 7,900 amid continued global investment programme
Andelyn Biosciences launches LVV Curator platform, bringing proven viral vector platform pedigree to Lentiviral Vector manufacturing for cell therapies

Andelyn Biosciences launches LVV Curator platform, bringing proven viral vector platform pedigree to Lentiviral Vector manufacturing for cell therapies

New platform leverages the established Curator platform methodology to industrialise Lentivirus processes from concept to clinic
Adragos Pharma appoints Kostas Rengis as Chief Executive Officer

Adragos Pharma appoints Kostas Rengis as Chief Executive Officer

Munich, Germany – May 7th, 2026 – Adragos Pharma, a global contract development and manufacturing organisation (CDMO), today announced the appointment of Konstantinos...
Syngene strengthens leadership team with two key appointments to support next phase of growth

Syngene strengthens leadership team with two key appointments to support next phase of growth

Abhijit Zutshi joins as CCO and Maninder Kapoor Puri as CHRO. India/U.S./UK, 1 May 2026: Syngene International, a global contract research, development, and manufacturing...
Former Catalent Chair and CEO George Fotiades joins eXmoor Pharma board as Chair

Former Catalent Chair and CEO George Fotiades joins eXmoor Pharma board as Chair

Angela Osborne steps back from operational duties and continues as Founder and Board Director, providing strategic continuity as eXmoor builds the leadership depth to...
Lonza completes transformation to pure-play CDMO with agreement to divest Capsules & Health Ingredients

Lonza completes transformation to pure-play CDMO with agreement to divest Capsules & Health Ingredients

Sale of CHI business to Lone Star funds marks final step in Lonza’s strategic shift to a focused CDMO model
Piramal Pharma Limited announces results for Q3 and 9M FY26

Piramal Pharma Limited announces results for Q3 and 9M FY26

Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated...
Almac announces multi-million-pound investment in Singapore

Almac announces multi-million-pound investment in Singapore

Almac Group has announced a multi-million-pound investment to expand its facility in Singapore, as the company marks ten years of operations in the country
CARBOGEN AMCIS secures refinancing to support growth and investment

CARBOGEN AMCIS secures refinancing to support growth and investment

CARBOGEN AMCIS today announced the successful refinancing and enhancement of its credit facilities through the banking syndication led by UBS Switzerland AG
Piramal Pharma reports Q2 and H1 FY26 results amid CDMO challenges

Piramal Pharma reports Q2 and H1 FY26 results amid CDMO challenges

CDMO growth impacted by inventory destocking while consumer healthcare posts mid-teen growth
Gerresheimer adjusts 2025 guidance amid slower market growth

Gerresheimer adjusts 2025 guidance amid slower market growth

Transformation program launched to boost performance and free cash flow